v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net increase (decrease) in net assets resulting from operations $ 46,958,761 $ 27,344,815
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net realized (gain) loss 4,453,195 2,191,492
Change in net unrealized (appreciation) depreciation of investments 30,355,318 4,651,804
Net amortization of investment discounts and premiums (3,901,388) (2,422,408)
Interest and dividend income paid in kind (1,613,142) (1,300,522)
Amortization of deferred debt issuance costs 1,317,218 532,062
Changes in assets and liabilities:    
Purchases of investments (462,358,430) (844,230,125)
Proceeds from disposition of investments 163,032,317 136,842,703
Decrease (increase) in interest, dividends and fees receivable (1,857,891) (3,347,154)
Decrease (increase) in receivable for investments sold 19,481,201 (18,423,375)
Decrease (increase) in prepaid expenses and other assets (1,625,588) 567,160
Increase (decrease) in interest and debt related payables 5,579,610 5,247,065
Increase (decrease) in incentive fees payable (118,112) (1,392,007)
Increase (decrease) in management fees payable 836,163 (890,682)
Increase (decrease) in accrued capital gains incentive fees 0 (498,552)
Increase (decrease) in reimbursements due to the Investment Adviser 41,174 (1,031,040)
Increase (decrease) in payable for investments purchased (55,621,496) 53,815,373
Increase (decrease) in accrued expenses and other liabilities 102,786 716,198
Net cash provided by (used in) operating activities (254,938,304) (641,627,193)
Financing activities    
Proceeds from common shares sold 161,068,633 256,121,310
Proceeds from issuance of Notes 0 55,000,000
Draws on credit facilities 151,243,775 674,000,000
Repayments of credit facility draws (7,948,054) (330,000,000)
Payments of debt issuance costs (4,387,665) (1,400,533)
Dividends paid in cash to shareholders (50,438,820) (17,668,060)
Payments of repurchased shares (98,647,197) (4,792,607)
Net cash provided by (used in) financing activities 150,890,672 631,260,110
Net increase (decrease) in cash and cash equivalents (including restricted cash) (104,047,632) (10,367,083)
Cash and cash equivalents (including restricted cash) at beginning of period 221,222,080 41,078,437
Cash and cash equivalents (including restricted cash) at end of period 117,174,448 30,711,354
Supplemental cash flow information    
Interest payments 21,765,934 11,718,133
Excise tax payments 0 0
Distribution payable 12,355,155 8,572,969
Reinvestment of dividends during the period $ 28,430,569 $ 24,669,640